Sponsor
Protagonist Therapeutics Inc.
7707 Gateway Boulevard, 94560-1160, United States
About the sponsor
Protagonist Therapeutics Inc. is focused on polycythemia vera, a myeloproliferative neoplasm associated with abnormal red blood cell production and the need for ongoing hematocrit control. Its clinical research centers on treatment strategies for managing this chronic blood disorder.
- Polycythemia vera
- Hematocrit control
- Red blood cell overproduction
The sponsor’s research activity in this area reflects interest in improving disease control for patients living with persistent erythrocytosis and related complications.
Try clearing a filter, or search the whole catalogue.
Are you running a clinical trial?
Increase visibility for your trials and help patients find your site through our platform.